Chimerix (CMRX) Reports In-Line Q1 EPS, Announces Strategy Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Chimerix Announces First Quarter 2019 Financial Results and Strategy Update
May 9, 2019 8:00 AM EDTReports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission
Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir Development Activities
Restructuring to Reduce Workforce by More Than 50%, Maintaining Key Capabilities and Preserving Capital for New Programs
Conference Call at 8:30 a.m. ET Today
DURHAM, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), today reported financial results for the first quarter ended March 31, 2019 and provided an update on... More
